The New England journal of medicine, 2023-02, Vol.388 (6), p.483-485
2023
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- A “Method of Use” to Prevent Generic and Biosimilar Market Entry
- Ist Teil von
- The New England journal of medicine, 2023-02, Vol.388 (6), p.483-485
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- A critical pathway that generics and biosimilars manufacturers have used to circumvent patent thickets has been “skinny labeling.” But a recent court ruling has placed this pathway under threat.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMp2216020Titel-ID: cdi_proquest_miscellaneous_2773117437
- Format
- –
- Schlagworte
- and the FDA, Biological products, Biosimilar Pharmaceuticals - economics, Biosimilar Pharmaceuticals - therapeutic use, Brand names, Devices, Drug Costs, Drug Industry - economics, Drug Industry - legislation & jurisprudence, Drugs, Drugs, Generic - economics, Drugs, Generic - therapeutic use, Economic Competition - economics, Economic Competition - legislation & jurisprudence, FDA approval, Federal court decisions, Generic drugs, Health Law, Health Policy, Heart failure, Humans, Hypertension, Infringement, Labeling, Manufacturers, Market entry, Patents as Topic - legislation & jurisprudence, Pharmaceutical industry